- Investing Ideas
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
BioGaia
Market Cap: SEK 12.3b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.90
7D
-6.6%
1Y
14.5%
Vitrolife
Market Cap: SEK 13.0b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 91.90
7D
-2.9%
1Y
-34.2%
Camurus
Market Cap: SEK 32.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 513.00
7D
-5.6%
1Y
-12.9%
AddLife
Market Cap: SEK 19.6b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 158.40
7D
2.1%
1Y
-17.9%
Bonesupport Holding
Market Cap: SEK 14.5b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 218.20
7D
-3.2%
1Y
-17.6%
BioArctic
Market Cap: SEK 26.2b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 286.00
7D
0.4%
1Y
45.1%
Swedish Orphan Biovitrum
Market Cap: SEK 150.4b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 430.40
7D
-1.2%
1Y
53.4%